Article
Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection.
Transactions of the Royal Society of Tropical Medicine and Hygiene - 8 Apr 2020
Cordie Ahmed, Elsharkawy Aisha, Abdel Alem Shereen, Meshaal Safa, El Akel Wafaa, Abdellatif Zeinab, Kamal Walid, Al Askalany Mahmoud, Kamel Sherif, Abdel Aziz Hossam, Kandeel Amr, Esmat Gamal
Abstract excerpt
BACKGROUND: Novel direct-acting antiviral agents have shown great efficacy and tolerability in HCV-monoinfected patients. However, data are lacking regarding their efficacy and safety in HIV/HCV-genotype (GT) 4-coinfected patients. METHODS: A single-centre, prospective study including HIV/HCV-GT 4-coinfected patients who were treated with sofosbuvir and daclatasvir (SOF/DCV) was conducted for 12 wk. Sustained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.